Are Hypoglycaemia and Other Adverse Effects Similar Among Sulphonylureas?-Reference-Cited by-同舟云学术

Are Hypoglycaemia and Other Adverse Effects Similar Among Sulphonylureas?

Published:2002-12 Issue:4 Volume:21 Page:205-217
ISSN:0964-198X
Container-title:Adverse Drug Reactions and Toxicological Reviews
language:en
Short-container-title:Adv Drug React Toxicol Rev

Author:

Salas Maribel,Caro Jaime J.

Publisher

Springer Science and Business Media LLC

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology

Link

http://link.springer.com/content/pdf/10.1007/BF03256197.pdf

Reference115 articles.

1. Lebovitz HE. Oral antidiabetic agents. In: Kahn RG, Weir GC, editors. Joslin’s diabetes mellitus. 13th ed. Philadelphia (PA): Lea & Febiger, 1994: 509–29

2. Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes. JAMA 2002; 287: 3609–372

3. Ferner RE. Oral hypoglycemic agents. Med Clin North Am 1988; 72: 1323–35

4. Groth CG, Tyden G, Ostman J. Fifteen years’ experience with pancreas transplantation with pancreaticoenterostomy. Diabetes 1989; 38Suppl. 1: 13–5

5. Melander A, Bitzen PO, Faber O, et al. Sulphonylureas antidiabetic drugs: an update of their clinical pharmacology and rational therapeutic use. Drugs 1989; 37: 58–72

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Controlled release of glibenclamide from monolithic silica subdermal implants produced by the sol-gel process and its use for hyperglycaemia treatment in a murine model;Materials Science and Engineering: C;2019-01

2. Hypoglycaemia when adding sulphonylurea to metformin: a systematic review and network meta-analysis;British Journal of Clinical Pharmacology;2016-08-03

3. The Hypoglycemic Risk of Glyburide (Glibenclamide) Compared with Modified-Release Gliclazide;Canadian Journal of Diabetes;2015-11

4. The Hypoglycemic Risk of Glyburide (Glibenclamide) Compared with Modified-Release Gliclazide;Canadian Journal of Diabetes;2015-08

5. Considerations for assessing the potential effects of antidiabetes drugs on cardiac ventricular repolarization: A report from the Cardiac Safety Research Consortium;American Heart Journal;2015-07